The DOI matches its Crossref record; 135 of the 137 references it cites were found in a registry or an index.
NF-κB in the liver—linking injury, fibrosis and hepatocellular carcinoma
Open accessAbstract
Hepatic cirrhosis and hepatocellular carcinoma (HCC) are the most common causes of death in patients with chronic liver disease. Chronic liver injury of virtually any etiology triggers inflammatory and wound-healing responses that in the long run promote the development of hepatic fibrosis and HCC. Here, we review the role of the transcription factor nuclear factor-κB (NF-κB), a master regulator of inflammation and cell death, in the development of hepatocellular injury, liver fibrosis and HCC, with a particular focus on the role of NF-κB in different cellular compartments of the liver. We propose that NF-κB acts as a central link between hepatic injury, fibrosis and HCC, and that it may represent a target for the prevention or treatment of liver fibrosis and HCC. However, NF-κB acts as a two-edged sword and inhibition of NF-κB may not only exert beneficial effects but also negatively impact hepatocyte viability, especially when NF-κB inhibition is pronounced. Finding appropriate targets or identifying drugs that either exert only a moderate effect on NF-κB activity or that can be specifically delivered to nonparenchymal cells will be essential to avoid the increase in liver injury associated with complete NF-κB blockade in hepatocytes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, the decisive factor is that NF-κB-activation additionally causes a significantly increased resistance against apoptosis in aHSCs.[21]”
From Nuclear receptors in liver fibrosis (2021) · cites this paper as [21]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sorafenib in advanced hepatocellular carcinoma
Llovet, J. M., Ricci, S., Mazzaferro, V., Hilgard, P., Gane, E., Blanc, J.-F., de Oliveira, A. C., Santoro, A., Raoul, J.-L., Forner, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708857 · Cited by 13,097
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults
Calle, E. E., Rodriguez, C., Walker-Thurmond, K., & Thun, M. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021423 · Cited by 7,696
Sorafenib in Advanced Hepatocellular Carcinoma
정, 재. (2008) · Cited by 5,586
Bataller, R., & Brenner, D. A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24282 · Cited by 4,958
Phosphorylation meets ubiquitination: the control of NF-κB activity
Karin, M., & Ben-Neriah, Y. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.621 · Cited by 4,766
Activators and target genes of Rel/NF-κB transcription factors
Pahl, H. L. (1999) · Oncogene · doi:10.1038/sj.onc.1203239 · Cited by 3,727
TLR4 links innate immunity and fatty acid-induced insulin resistance
Shi, H., Kokoeva, M. V., Inouye, K., Tzameli, I., Yin, H., & Flier, J. S. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28898 · Cited by 3,690
Missing Pieces in the NF-κB Puzzle
Ghosh, S., & Karin, M. (2002) · Cell · doi:10.1016/s0092-8674(02)00703-1 · Cited by 3,638
Activators and Target Genes of Rel/NF-кB Transcription Factors
Loop, T., & Pahl, H. L. (2003) · Springer eBooks · doi:10.1007/978-94-010-0163-2_1 · Cited by 3,179
An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death
Beg, A. A., & Baltimore, D. (1996) · Science · doi:10.1126/science.274.5288.782 · Cited by 3,047
Cited by
Sorted by citations
Items 901–999 of 999
Zhu, Y., Liu, C., Chen, X., Lu, S., & Chen, J. (2020) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-020-02957-w · Cited by 9
Bala, S., Calenda, C. D., Catalano, D. E., Babuta, M., Kodys, K., Nasser, I. A., Vidal, B., & Szabó, G. (2020) · Hepatology Communications · doi:10.1002/hep4.1540 · Cited by 9
Strategic approach in hepatic delivery of andrographolide: Key challenges and new insights
Mandal, D. D., Mandal, T., & Hazra, M. (2020) · Journal of Herbal Medicine · doi:10.1016/j.hermed.2020.100411 · Cited by 9
Suzuki‐Kemuriyama, N., Abe, A., Uno, K., Ogawa, S., Watanabe, A., Sano, R., Yuki, M., Miyajima, K., & Nakae, D. (2020) · Lipids in Health and Disease · doi:10.1186/s12944-020-01423-3 · Cited by 9
Hussain, Z., Khan, J. A., Arshad, M. I., Muhammad, F., & Abbas, R. Z. (2021) · Boletin Latinoamericano y del Caribe de plantas Medicinales y Aromaticas · doi:10.37360/blacpma.21.20.4.25 · Cited by 10
Peng, T., Wonganan, O., Zhang, Z., Yu, J., Xi, R., Cao, Y., Suksamrarn, A., Zhang, G., & Wang, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073354 · Cited by 9
Wang, B., Wu, Z., Li, W., Liu, G., & Tang, Y. (2021) · Chinese Medicine · doi:10.1186/s13020-021-00473-8 · Cited by 9
Singh, T. R., & Ezhilarasan, D. (2021) · Drug and Chemical Toxicology · doi:10.1080/01480545.2021.1945079 · Cited by 9
Zhang, Y., Shao, J., Li, S., Liu, Y., & Zheng, M. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.775250 · Cited by 9
Yuan, D., Ma, R., Sun, T., Zhu, K., Dang, C., Ye, H., & Li, K. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02515-z · Cited by 9
Retard or exacerbate: Role of long non-coding RNA growth arrest-specific 5 in the fibrosis
Xiang, Z., Liqing, Y., Qingqing, Y., He, Q., & Chen, H. (2022) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2022.06.001 · Cited by 9
Liatsos, G. D. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i16.2397 · Cited by 10
Jeng, J., Wu, H., Tsai, M.-F., Tsai, H.-R., Chuang, L., Lin, Z., Hsieh, M., Chen, S., Chuang, W.-L., Wang, L., et al. (2015) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.23.10209 · Cited by 9
Fukui, H. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804274-8.00027-8 · Cited by 9
Lei, M. M. L., & Lee, T. K. (2021) · Hepatology · doi:10.1002/hep.31768 · Cited by 9
Mohammad, S., Zoubi, S. A., Collotta, D., Krieg, N., Wissuwa, B., Alves, G. F., Purvis, G. S. D., Norata, G. D., Baragetti, A., Catapano, A. L., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.701275 · Cited by 7
RetractedMicroRNAs in adipose tissue fibrosis: Mechanisms and therapeutic potential
Tian, M., Zhou, Y., Guo, Y., Xia, Q., Wang, Z., Zheng, X., Shen, J., Guo, J., Duan, S., & Wang, L. (2024) · Genes & Diseases · doi:10.1016/j.gendis.2024.101287 · Cited by 8
Progranulin: A promising biomarker and therapeutic target for fibrotic diseases
Yang, F., Cheng, M.-H., Pan, H., & Gao, J. X. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.04.026 · Cited by 10
Parekh, N. M., Desai, R. S., Bansal, S. P., Shirsat, P. M., & Prasad, P. S. (2024) · Cytokine · doi:10.1016/j.cyto.2024.156742 · Cited by 7
Extracellular vesicle‐encapsulated miR ‐30c‐5p reduces aging‐related liver fibrosis
Rodrigues, A. C., Heng, Y. J., & Slack, F. J. (2024) · Aging Cell · doi:10.1111/acel.14310 · Cited by 10
Roulot, D. M., Layese, R., Brichler, S., Ganne‐Carrié, N., Asselah, T., Zoulim, F., Gordien, E., Nahon, P., Roudot‐Thoraval, F., Nahon, P., et al. (2024) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2024.08.046 · Cited by 8
Jia, G.-G., Lu, L., Li, B., Li, C., Zheng, Y., Zhang, J.-C., He, Y., Xu-Shi, & Yu, X. (2024) · Experimental Cell Research · doi:10.1016/j.yexcr.2024.114361 · Cited by 8
Li, Z., Luo, J., Peng, L., Wu, B., & Yu, Z. (2025) · Clinical & Translational Oncology · doi:10.1007/s12094-025-04028-3 · Cited by 8
Namkhah, Z., Naeini, F., Ostadrahimi, A., Tutunchi, H., & Hosseinzadeh‐Attar, M. J. (2021) · International Journal of Clinical Practice · doi:10.1111/ijcp.13985 · Cited by 8
Quenum, A., Shukla, A., Rexhepi, F., Cloutier, M., Ghosh, A., Kufer, T. A., Ramanathan, S., & Ilangumaran, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.749646 · Cited by 10
Supriono, S., Kalim, H., Permatasari, N., & Susianti, H. (2022) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2022.9119 · Cited by 8
Inhibition of STAT3-NF-κB pathway facilitates SSPH I-induced ferroptosis in HepG2 cells
Sun, Y., Huang, D. A., Li, J., Zhou, Y., Zhou, G., & Chen, Q. (2024) · Medical Oncology · doi:10.1007/s12032-024-02425-2 · Cited by 8
Zhang, X., Ge, Y., Ye, M., Wang, X., Tong, Y., Liu, C., Xu, S., Zhao, Z., You, Q., Guo, X., et al. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.02.042 · Cited by 8
Block, P. D., Shinn, B., Kim, J. H., & HANN, H.-W. L. (2020) · Hepatic Oncology · doi:10.2217/hep-2020-0028 · Cited by 8
The case for FAT10 as a novel target in fatty liver diseases
Wimalarathne, M. M., Wilkerson-Vidal, Q. C., Hunt, E. C., & Love-Rutledge, S. T. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.972320 · Cited by 8
Stärkel, P., Saeger, C. D., Delire, B., Magat, J., Jordan, B. F., Konda, V. R., Tripp, M. L., & Borbath, I. (2015) · Nutrition and Cancer · doi:10.1080/01635581.2015.1032429 · Cited by 8
Activation of NF-κB signaling in hepatocytes induces liver fibrosis
Ray, K. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.61 · Cited by 8
Synthesis and biological evaluation of T-OA analogues as the cytotoxic agents
Xu, K., Xu, X., Chu, F., Wang, M., Wang, P., Li, G., Song, J., Zhang, Y., & Lei, H. (2014) · Research on Chemical Intermediates · doi:10.1007/s11164-014-1737-z · Cited by 8
Melatonin Ameliorates Burn-Induced Liver Injury by Modulation of Nrf2 and Nf- kB Signaling Pathways
Bekyarova, G. Y. (2015) · SOJ Immunology · doi:10.15226/soji/3/2/00128 · Cited by 8
Galicia‐Moreno, M., Monroy-Ramírez, H. C., Campos-Valdez, M., Sánchez-Meza, J., Sánchez-Orozco, L. V., & Armendáriz‐Borunda, J. (2020) · Hepatoma Research · doi:10.20517/2394-5079.2019.36 · Cited by 8
Chang, S., Wang, L. H.-C., & Chen, B. (2020) · Biomedicines · doi:10.3390/biomedicines8090320 · Cited by 8
The NF ‐ κB Signalling Pathway: Mechanisms, Consequences and Therapeutic Targets
Pourdad, B., & Pourdad, A. (2026) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.71229 · Cited by 8
New targeted approaches against the ubiquitin–proteasome system in gastrointestinal malignancies
Grande, E., Earl, J., Fuentes, R., & Carrato, A. (2012) · Expert Review of Anticancer Therapy · doi:10.1586/era.12.26 · Cited by 7
He, L., Wang, X., Ding, Z., Liu, L., Cheng, H., Bily, D., Wu, C., Zhang, K., & Xie, L. (2022) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2022.109157 · Cited by 7
Huang, F., Wang, H., Zhang, Y. E., Wei, G., Xie, Y., & Wu, G. H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097707 · Cited by 7
Chronic Liver Disease in Patients with Prolidase Deficiency: A Case Series
Gopalakrishna, H., Asif, B., Rai, A., Conjeevaram, H. S., Mironova, M., Kleiner, D. E., Freeman, A. F., & Heller, T. (2024) · Case Reports in Gastroenterology · doi:10.1159/000536117 · Cited by 7
Ali, F. E. M., Ibrahim, I. M., Althagafy, H. S., & Hassanein, E. H. M. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112011 · Cited by 7
Research Progress of Chinese Medicine in the Regulation of Liver Fibrosis-Related Signaling Pathways
Zheng, S., Xue, C., Li, S., Qi, W., Zao, X., Li, X., Wang, W., Liu, Q., Cao, X., Zhang, P., et al. (2024) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x24500666 · Cited by 7
Saraswat, I., & Goel, A. (2024) · Current Pharmaceutical Design · doi:10.2174/0113816128348771240925100639 · Cited by 7
Kuijpers, T., Wolters, J. E. J., Kleinjans, J. C. S., & Jennen, D. G. J. (2019) · BMC Bioinformatics · doi:10.1186/s12859-019-2995-y · Cited by 7
Polyphenolic extracts from Wushan tea leaves attenuate hepatic injury in CCl4-treated mice
Sha, J., Song, J., Yu, M., Zhao, X., Wang, H., Zhang, Y., & Suo, H. (2020) · Journal of Functional Foods · doi:10.1016/j.jff.2020.103826 · Cited by 7
Proteomic basis of modulation of postischemic fibrosis by MSC exosomes
Kore, R. A., Wang, X., Henson, J. C., Ding, Z., Jamshidi‐Parsian, A., & Mehta, J. L. (2021) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00124.2021 · Cited by 7
Yeo, E., Shin, M. W., Yeo, H. J., Choi, Y. J., Sohn, E. J., Lee, L., Kwon, H., Cha, H., Lee, S., Lee, S., et al. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10831 · Cited by 7
MicroRNA-137-3p Improves Nonalcoholic Fatty Liver Disease through Activating AMPKα
Yu, Y., He, C., Tan, S., Huang, M., Guo, Y., Li, M., & Zhang, Q. (2021) · Analytical Cellular Pathology · doi:10.1155/2021/4853355 · Cited by 7
Yadahalli, R., Sarode, G. S., Sarode, S. C., Khan, Z. A., Vyas, N., Kharat, A. H., Bhandi, S., Awan, K. H., & Patil, S. (2022) · Disease-a-Month · doi:10.1016/j.disamonth.2022.101351 · Cited by 7
Saffron extract attenuates Sofosbuvir‐induced retinal neurodegeneration in albino rat
Elseady, W. S., Keshk, W. A., Negm, W. A., Elkhalawany, W. A., Elhanafy, H., Ibrahim, M. A., & Radwan, D. A. (2022) · The Anatomical Record · doi:10.1002/ar.24942 · Cited by 7
Oh, K., Choi, Y. R., Gupta, H., Ganesan, R., Sharma, S. P., Won, S., Jeong, J., Lee, S.-B., Cha, M., Kwon, G.-H., et al. (2022) · Current Issues in Molecular Biology · doi:10.3390/cimb44070224 · Cited by 7
Lebda, F., Agaty, S. M. E., Ali, R. H., Hamam, G. G., Abd, A. M., & Lasheen, N. N. (2022) · General Physiology and Biophysics · doi:10.4149/gpb_202235 · Cited by 8
Alqahtani, S. M., Dawood, A. F., Kamar, S. S., Haidara, M. A., ShamsEldeen, A. M., Dallak, M. A., Al‐Ani, B., & Ebrahim, H. A. (2023) · International Journal of Morphology · doi:10.4067/s0717-95022023000100079 · Cited by 7
Yamada, K., Tanaka, T., Kai, K., Matsufuji, S., Ito, K., Kitajima, Y., Manabe, T., & Noshirο, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411546 · Cited by 7
Okrit, F., Chayanupatkul, M., Wanpiyarat, N., Siriviriyakul, P., & Werawatganon, D. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e26055 · Cited by 7
Zhan, Y., Liu, R., Wang, W., Li, J., Yang, X.-Y., & Zhang, Y. (2015) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2015.10.008 · Cited by 7
Intervention of transforming pulmonary fibrosis with NF-κB p65 antisense oligonucleotide.
Zhou, Y., Chen, Y., Zhang, X., Tan, M., Zheng, R., & Zhao, L. (2014) · PubMed Central · Cited by 7
More, A. N., Shah, T. V., Parab, P. B., & Apte, K. G. (2017) · Matters · doi:10.19185/matters.201704000014 · Cited by 7
Fan, H., Huang, P., Shao, J., Tian, T., Li, J., Zang, F., Liu, M., Xue, H., Wu, J., Yu, R., et al. (2018) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2018.07.031 · Cited by 7
Liu, A., Han, N., Munoz-Muriedas, J., & Bender, A. (2022) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1010148 · Cited by 7
Folschette, M., Legagneux, V., Poret, A., Chebouba, L., Guziołowski, C., & Théret, N. (2020) · BMC Bioinformatics · doi:10.1186/s12859-019-3316-1 · Cited by 7
Chen, M., Luo, J., Ji, H., Song, W., Zhang, D., Su, W., & Liu, S. (2023) · Marine Drugs · doi:10.3390/md21090477 · Cited by 6
LPS-Induced Liver Inflammation Is Inhibited by Psilocybin and Eugenol in Mice
Robinson, G. I., Gerasymchuk, M., Zanikov, T., Gojani, E. G., Asghari, S., Groves, A., Haselhorst, L., Nandakumar, S., Stahl, C., Cruz, C., et al. (2025) · Pharmaceuticals · doi:10.3390/ph18040451 · Cited by 6
Ning, B., Wang, S., Young, M.-J., Chen, Y.-C., Hung, Y., Hương, T. T., Chang, W., Wang, Y., Yu, M., Hsu, K., et al. (2025) · Journal of Biomedical Science · doi:10.1186/s12929-025-01148-4 · Cited by 6
Dong, Q., Wang, Y., He, Y., Gao, T., Li, L., Chen, L., Liu, C., Wang, W., Liu, X., Zhang, Y., et al. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.120269 · Cited by 6
Elhady, S. S., Wahba, A. S., Ibrahim, A. K., El-Sayyad, G. S., El-Batal, A. I., Wahba, N. S., Nafie, M. S., Ahmed, S. A., Ibrahim, A. K., Badr, J. M., et al. (2025) · ACS Omega · doi:10.1021/acsomega.5c03992 · Cited by 6
Duan, H., Gong, M., Yuan, G., & Wang, Z. (2024) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2024.102459 · Cited by 7
Lishai, E. A., Zaparina, O. G., Kapushchak, Y. K., Sripa, B., Hong, S.-J., Cheng, G., & Pakharukova, M. Y. (2024) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0012685 · Cited by 6
Prevention of Intrauterine Adhesion with Platelet‐Rich Plasma Double‐Network Hydrogel
Wang, Z., Gu, Y., Qu, Y., Huang, X., Sun, T., Wu, W., Hu, Q., Xiao, C., Yu, L. J., Zhao, H., et al. (2024) · Advanced Biology · doi:10.1002/adbi.202400336 · Cited by 6
Signal integrator function of CXXC5 in Cancer
An, Z., Wang, J., Li, C., & Tang, C. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-024-02005-x · Cited by 5
Das, C., & Kundu, C. N. (2025) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2025.2461045 · Cited by 6
Ishikawa, H., Hayakawa, M., Baatartsogt, N., Kakizawa, N., Ohto‐Ozaki, H., Maruyama, T., Miura, K., Suzuki, K., Rikiyama, T., & Ohmori, T. (2022) · Scientific Reports · doi:10.1038/s41598-022-15840-0 · Cited by 6
Lin, G.-H., Wu, S.-H., Ko, Y.-C., Lin, C., Liao, G., Chen, T.-W., Chen, Y., & Hsu, K. (2022) · Molecular Biotechnology · doi:10.1007/s12033-022-00568-z · Cited by 6
Therapeutic Potential of Herbal Medicine against Non-alcoholic Fatty Liver Disease
Avan, A., Pourali, G., Hosseini, Z. S., Maftooh, M., Nazari, E., Khazaei, M., Nassiri, M., Hassanian, S. M., Ghayour‐Mobarhan, M., Ferns, G. A., et al. (2023) · Current Drug Targets · doi:10.2174/1389450124666230113150116 · Cited by 6
Li, L., Ai, R., Yuan, X., Dong, S., Zhao, D., Sun, X., Miao, T., Guan, W., Guo, P., Yu, S., et al. (2023) · Journal of Hepatocellular Carcinoma · doi:10.2147/jhc.s410891 · Cited by 6
Ma, K., Hu, X., Nambu, K., Ueda, D., Ichimaru, N., Fujino, M., & Li, X. (2023) · Scientific Reports · doi:10.1038/s41598-023-38856-6 · Cited by 6
Bae, S., Park, J., & Jun, W. (2024) · Journal of Functional Foods · doi:10.1016/j.jff.2024.106038 · Cited by 6
Cellular Interactions in the Human Fatty Liver
Sovaila, S., Silvia Sovaila, 2. P. R. S., Purcărea, A., Gheonea, D. I., Ionescu, S. O., & Ciurea, T. (2019) · Journal of Medicine and Life · doi:10.25122/jml-2019-1010 · Cited by 6
Ceccherini, E., Cecchettini, A., Morales, M. A., & Rocchiccioli, S. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00813 · Cited by 6
Pradhan‐Sundd, T., Liu, S., Singh, S., Poddar, M., Ko, S., Bell, A. W., Franks, J. M., Huck, I., Stolz, D. B., Apte, U. M., et al. (2021) · American Journal Of Pathology · doi:10.1016/j.ajpath.2021.02.008 · Cited by 6
Xie, S.-Z., Zhai, X., Xi, S., Qiu, Y., Zhang, Y., Kong, X., Li, Y.-H., Zhu, L., Wang, Z., Zhang, S.-G., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.764282 · Cited by 6
Hepatic Stellate Cells and Liver Cancer
Dapito, D. H., & Schwabe, R. F. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800134-9.00009-9 · Cited by 5
Self-citationSix‐way decomposition of causal effects: Unifying mediation and mechanistic interaction
Huang, Y., Tai, A., Chou, M.-Y., Lin, G., & Lin, S. (2020) · Statistics in Medicine · doi:10.1002/sim.8708 · Cited by 6
Dynamic regulatory module networks for inference of cell type–specific transcriptional networksPreprint
Siahpirani, A. F., Knaack, S., Chasman, D. A., Seirup, M., Sridharan, R., Stewart, R. M., Thomson, J. L., & Roy, S. (2022) · Genome Research · doi:10.1101/gr.276542.121 · Cited by 6
Zuo, W.-T., Ma, H., Bi, J., Li, T., Mo, Y., Shiyu, Y., Wang, J., Li, B., Huang, J., Li, Y., et al. (2023) · Gastroenterology report · doi:10.1093/gastro/goae094 · Cited by 5
Non-Invasive Biomarkers and Breath Tests for Diagnosis and Monitoring of Chronic Liver Diseases
Boon‐yasidhi, P., & Karnsakul, W. W. (2024) · Diagnostics · doi:10.3390/diagnostics15010068 · Cited by 5
Garcia, V. B., Gasparotto, L. H. S., de Araújo, A. A., Leitão, R. F. D. C., Brito, G. A. D. C., Vilar, N. F., de Oliveira, E. L., Guedes, P. M. D. M., & Júnior, R. F. D. A. (2025) · ACS Omega · doi:10.1021/acsomega.4c10118 · Cited by 6
Pharmacologic inhibition of HNF4α prevents parenteral nutrition associated cholestasis in mice
Ghosh, S., Devereaux, M. W., Orlicky, D. J., & Sokol, R. J. (2023) · Scientific Reports · doi:10.1038/s41598-023-33994-3 · Cited by 5
Guo, C., Wang, X., Dai, D., Kong, F., Wang, S., Sun, X., Li, S., Xu, X., & Zhang, L. (2023) · Frontiers in Veterinary Science · doi:10.3389/fvets.2023.1282055 · Cited by 5
Khalaf, S. E., Abdelfattah, S. N., & Hasona, N. A. (2024) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-024-01203-1 · Cited by 5
Yan, D., Zhang, X., Ma, C., Huang, W., Hao, M., & Xie, L. (2024) · Pharmaceuticals · doi:10.3390/ph17091128 · Cited by 5
Zheng, J., Xiao, J., Fan, Y., Zheng, H., Liu, H., Xiang, J., Hai, L., Wang, Y., & Zhang, X. (2024) · European Journal of Immunology · doi:10.1002/eji.202451178 · Cited by 5
Zhang, T., Jie, J., Liang, Y., Luo, J., Cheng, D., Qin, S., & Jiang, H. (2025) · Genomics · doi:10.1016/j.ygeno.2025.111043 · Cited by 5
Potential role of terpenes in recovery from olfactory dysfunction with olfactory training: a review
Altundağ, A., & Harbi, E. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-10795-7 · Cited by 6
Chu, M., Tong, Y., Zhang, L., Zhang, Y. X., Dang, J., & Li, G. (2025) · Nutrients · doi:10.3390/nu17152456 · Cited by 5
Jeon, K., Kim, S., Park, S., Pak, E. S., Kim, S., Lee, H. J., Kim, T., Piao, J. J., Shin, D., Bae, W. J., et al. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118463 · Cited by 5
ILDR2 has a negligible role in hepatic steatosis
Millings, E. J., Rosa, M. C. D., Fleet, S. E., Watanabe, K., Rausch, R. N., Egli, D. M., Li, G., LeDuc, C. A., Zhang, Y., Fischer, S. G., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0197548 · Cited by 4
HJC0416 Attenuates Fibrogenesis in Activated Hepatic Stellate Cells via STAT3 and NF-κB Pathways
Sommerhalder, C., Cummins, C. B., Wang, X., Ramdas, D., Lopez, O. N., Gu, Y., Zhou, J., & Radhakrishnan, R. S. (2021) · Journal of Surgical Research · doi:10.1016/j.jss.2020.12.045 · Cited by 6
Metadata
- Authors
- Luedde, T., & Schwabe, R. F.
- Affiliations
- Universitätsklinikum Aachen (DE)
- Columbia University Irving Medical Center (US)
- Corresponding author
- Luedde, Tom
- Schwabe, Robert F.
- Venue
- Nature Reviews Gastroenterology & Hepatology
- Published
- 2011-02
- Volume
- 8
- Issue
- 2
- Pages
- 108-118
- ISSN
- 1759-5045 (ISSN-L)
- 1759-5053
- PMC
- PMC3295539
- OpenAlex
- W1976777085
- Cited by
- 1,345
- References
- 137
- Citations by year
- 2026: 97 · 2025: 99 · 2024: 119 · 2023: 109 · 2022: 122 · 2021: 156 · 2020: 120 · 2019: 95 · 2018: 79 · 2017: 76 · 2016: 66 · 2015: 68 · 2014: 51 · 2013: 38 · 2012: 42
- FWCI
- 5.65
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Gastroenterology & Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (5u54ca126513-03)
- National Institute on Alcohol Abuse and Alcoholism (R01AA020211)
- National Cancer Institute (U54 CA126513.)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK076920)
- National Center for Complementary and Integrative Health (R21AT003878)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
- Keywords
- NF-κB, liver fibrosis, hepatocellular carcinoma, chronic liver disease, liver cirrhosis, chronic liver injury, liver inflammation, hepatocytes, non-parenchymal liver cells, NF-κB inhibition, hepatocyte viability
- MeSH terms
- Cell Survival, Fibrosis, Carcinoma, Hepatocellular, Homeostasis, Humans, Liver, Liver Neoplasms, NF-kappa B, Hepatocytes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
